{"id":"https://openalex.org/W3044638641","doi":"https://doi.org/10.1177/1060028020943527","title":"PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines","display_name":"PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines","publication_year":2020,"publication_date":"2020-07-22","ids":{"openalex":"https://openalex.org/W3044638641","doi":"https://doi.org/10.1177/1060028020943527","mag":"3044638641","pmid":"https://pubmed.ncbi.nlm.nih.gov/32698599"},"language":"en","primary_location":{"id":"doi:10.1177/1060028020943527","doi":"https://doi.org/10.1177/1060028020943527","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1060028020943527","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088987381","display_name":"Mary Beth Gadarowski","orcid":"https://orcid.org/0000-0003-3835-6697","observed_orcids":["https://orcid.org/0000-0003-3835-6697"]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mary B. Gadarowski","raw_affiliation_strings":["Wake Forest School of Medicine, Winston-Salem, NC, USA"],"raw_orcid":"https://orcid.org/0000-0003-3835-6697","affiliations":[{"raw_affiliation_string":"Wake Forest School of Medicine, Winston-Salem, NC, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075579508","display_name":"Rima I. Ghamrawi","orcid":"https://orcid.org/0000-0001-6325-7581","observed_orcids":["https://orcid.org/0000-0001-6325-7581"]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rima I. Ghamrawi","raw_affiliation_strings":["Wake Forest School of Medicine, Winston-Salem, NC, USA"],"raw_orcid":"https://orcid.org/0000-0001-6325-7581","affiliations":[{"raw_affiliation_string":"Wake Forest School of Medicine, Winston-Salem, NC, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103682730","display_name":"Sarah L. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah L. Taylor","raw_affiliation_strings":["Wake Forest School of Medicine, Winston-Salem, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest School of Medicine, Winston-Salem, NC, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006964107","display_name":"Steven R. Feldman","orcid":"https://orcid.org/0000-0002-0090-6289","observed_orcids":["https://orcid.org/0000-0002-0090-6289"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]},{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Steven R. Feldman","raw_affiliation_strings":["University of Southern Denmark, Odense, Denmark","Wake Forest School of Medicine, Winston-Salem, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern Denmark, Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]},{"raw_affiliation_string":"Wake Forest School of Medicine, Winston-Salem, NC, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5088987381"],"corresponding_institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.5909,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.65740124,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"55","issue":"3","first_page":"354","last_page":"361"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11322","display_name":"Facial Rejuvenation and Surgery Techniques","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11322","display_name":"Facial Rejuvenation and Surgery Techniques","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12301","display_name":"Facial Nerve Paralysis Treatment and Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/botulinum-toxin-type-a","display_name":"botulinum toxin type A","score":0.8790000081062317},{"id":"https://openalex.org/keywords/glabellar-lines","display_name":"glabellar lines","score":0.9950000047683716},{"id":"https://openalex.org/keywords/frown-lines","display_name":"frown lines","score":0.675000011920929},{"id":"https://openalex.org/keywords/aesthetic-treatment","display_name":"aesthetic treatment","score":0.4180000126361847},{"id":"https://openalex.org/keywords/onabotulinumtoxina","display_name":"onabotulinumtoxinA","score":0.9580000042915344},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.40400001406669617},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.9359999895095825},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9009379744529724},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4273624122142792}],"mesh":[{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005546","descriptor_name":"Forehead","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/1060028020943527","doi":"https://doi.org/10.1177/1060028020943527","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1060028020943527","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:32698599","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32698599","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/f326ce39-ca84-4a68-9717-ae73e8599a86","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/f326ce39-ca84-4a68-9717-ae73e8599a86","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Gadarowski, M B, Ghamrawi, R I, Taylor, S L & Feldman, S R 2021, 'PrabotulinumtoxinA-xvfs for the Treatment of Moderate-to-Severe Glabellar Lines', Annals of Pharmacotherapy, vol. 55, no. 3, pp. 354-361. https://doi.org/10.1177/1060028020943527","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1978648826","https://openalex.org/W1982308559","https://openalex.org/W2030907440","https://openalex.org/W2063923616","https://openalex.org/W2123017079","https://openalex.org/W2134833483","https://openalex.org/W2162793583","https://openalex.org/W2925222137","https://openalex.org/W2934071779"],"related_works":["https://openalex.org/W2925222137","https://openalex.org/W7221824338","https://openalex.org/W4393002660","https://openalex.org/W7106319663","https://openalex.org/W4249436631","https://openalex.org/W2934071779","https://openalex.org/W3159048288","https://openalex.org/W1978910356","https://openalex.org/W2030342052","https://openalex.org/W3160687635"],"abstract_inverted_index":{"Objective":[0],"PrabotulinumtoxinA-xvfs":[1],"(Jeuveau),":[2],"a":[3,118,210,233],"botulinum":[4],"toxin":[5],"type":[6],"A,":[7],"was":[8,59,73,194],"approved":[9],"by":[10],"the":[11,17,21,42,62,69,107,124,214,240,246],"Food":[12],"and":[13,36,45,81,91,97,150,154,187,204,216,220,228,235],"Drug":[14],"Administration":[15],"for":[16,245],"temporary":[18],"improvement":[19,122,173],"in":[20,27,68,86,156,174],"appearance":[22,247],"of":[23,48,140,213,218,242,248],"moderate-to-severe":[24],"glabellar":[25,249],"lines":[26,65],"February":[28],"2019.":[29],"This":[30,207],"article":[31],"will":[32],"review":[33,58,208],"phase":[34,95,98],"II":[35,96],"III":[37,99],"clinical":[38,46,100,162],"trials":[39,101,163],"to":[40,75,144,201,224,239],"assess":[41],"efficacy,":[43],"safety,":[44],"application":[47],"this":[49],"novel,":[50],"aesthetic-only":[51],"drug.":[52],"Data":[53,82,104],"sources":[54],"A":[55],"systematic":[56],"literature":[57],"performed":[60],"using":[61],"terms":[63],"\u201cglabellar":[64],"AND":[66],"prabotulinumtoxinA\u201d":[67],"PubMed":[70],"database.":[71],"ClinicalTrials.gov":[72],"searched":[74],"identify":[76],"nonpublished":[77],"studies.":[78,199],"Study":[79],"Selection":[80],"Extraction":[83],"Articles":[84],"written":[85],"English":[87],"between":[88],"November":[89],"2019":[90],"June":[92],"2020":[93],"discussing":[94],"were":[102,148],"evaluated.":[103],"Synthesis":[105],"By":[106],"primary":[108],"efficacy":[109,217],"end":[110],"point":[111],"on":[112,123,135,179],"day":[113,136,180],"30,":[114],"more":[115],"patients":[116,227],"achieved":[117],"greater":[119,172],"than":[120],"2-point":[121],"Glabellar":[125],"Line":[126],"Scale":[127],"(GLS)":[128],"at":[129,176],"maximum":[130,177],"frown":[131,178],"compared":[132,183],"with":[133,146,184],"baseline":[134],"0.":[137],"The":[138],"proportions":[139],"participants":[141],"who":[142],"responded":[143],"treatment":[145],"prabotulinumtoxinA":[147,170],"67.5%":[149],"70.4%":[151],"versus":[152],"1.2%":[153],"1.3%":[155],"placebo":[157,188],"groups":[158],"across":[159,197],"2":[160],"identical":[161],"(":[164],"P":[165,190],"<":[166,191],"0.001).":[167,192],"Patients":[168],"receiving":[169],"experienced":[171],"GLS":[175],"30":[181],"(87.2%)":[182],"onabotulinumtoxinA":[185],"(82.8%)":[186],"(4.2%;":[189],"PrabotulinumtoxinA":[193,231],"well":[195],"tolerated":[196],"all":[198],"Relevance":[200],"Patient":[202],"Care":[203],"Clinical":[205],"Practice":[206],"provides":[209],"detailed":[211],"analysis":[212],"safety":[215],"prabotulinumtoxinA-xvfs":[219],"includes":[221],"special":[222],"considerations":[223],"help":[225],"guide":[226],"clinicians.":[229],"Conclusion":[230],"is":[232],"safe":[234],"effective":[236],"new":[237],"addition":[238],"repository":[241],"available":[243],"treatments":[244],"lines.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-07-29T00:00:00"}